| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |